alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 7
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<DEBT-HELD-FOR-SALE>                           156,131
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                      36,433
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 192,564
<CASH>                                           8,525
<RECOVER-REINSURE>                               1,115
<DEFERRED-ACQUISITION>                           9,649
<TOTAL-ASSETS>                                 251,755
<POLICY-LOSSES>                                108,591
<UNEARNED-PREMIUMS>                             36,589
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                      0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        42,119
<OTHER-SE>                                      54,607
<TOTAL-LIABILITY-AND-EQUITY>                   251,755
<PREMIUMS>                                      47,551
<INVESTMENT-INCOME>                              4,615
<INVESTMENT-GAINS>                                (31)
<OTHER-INCOME>                                     114
<BENEFITS>                                      26,313
<UNDERWRITING-AMORTIZATION>                     14,804
<UNDERWRITING-OTHER>                             1,179
<INCOME-PRETAX>                                  9,953
<INCOME-TAX>                                     2,339
<INCOME-CONTINUING>                              7,614
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,614
<EPS-PRIMARY>                                     1.03
<EPS-DILUTED>                                     1.02
<RESERVE-OPEN>                                  85,723<F1>
<PROVISION-CURRENT>                             26,313
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                               3,710
<PAYMENTS-PRIOR>                                12,378
<RESERVE-CLOSE>                                 95,948<F1>
<CUMULATIVE-DEFICIENCY>                              0
<FN>
<F1>UNPAID LOSS AND LOSS ADJUSTMENT EXPENSES DIFFER FROM THE AMOUNTS REPORTED IN
THE CONSOLIDATED FINANCIAL STATEMENTS BECAUSE OF THE INCLUSION HEREIN OF
REINSURANCE RECEIVABLES OF $12,643 AND $10,919 AT JUNE 30, 1997 AND DECEMBER
31, 1996, RESPECTIVELY.
</FN>
        

</TABLE>
Alice BROWN, petitioner, v. DEL NORTE COUNTY, CALIFORNIA, et al.

No. 18-6507.

Supreme Court of the United States

Feb. 25, 2019.

Petition for rehearing denied.
----

Exhibit 32.2**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with amendment no.1 tothe Annual Report of EPOD International Inc. (the "Company") on Form 10-KSB/Afor the fiscal year ended December 31, 2006, as filed with the Securities andExchange Commission on November 14, 2007 (the "Report"), I, Frank A. Wisehart,Chief Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, tomy knowledge: (1) the Report fully complies with the requirements of Section13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) the informationcontained in the Report fairly presents, in all material respects, the financialcondition and results of operations of the Company. 

A signed original of this written statement requiredby Section 906 has been provided to and will be retained by EPOD International,Inc and furnished to the Securities and Exchange Commission or its staff uponrequest. /s/ Frank A.    Wisehart Frank A. Wisehart *Chief Financial    Officer* EPOD INTERNATIONAL    INC.
November 14, 2007Kelowna, British Columbia**
ARMED SERVICES BOARD OF CONTRACT APPEALS

Appeal of

- )

)

Booz Allen Hamilton, Inc. ) ASBCA No. 63188

)

Under Contract No. FA7014

- 20

- D

- 0008

T.O. FA7014

- 21

- F

- 0245 )

)

APPEARANCES FOR THE APPELLANT: Gary J. Campbell, Esq.

Miles A. McCann, Esq.

Womble Bond Dickinson (US) LLP

Washington, DC

APPEARANCES FOR THE GOVERNMENT: Jeffrey P. Hildebrant, Esq.

Deputy Chief Trial Attorney

Aaron J. Weaver, Esq.

Trial Attorney

ORDER OF DISMISSAL

The dispute has been settled. The appeal is dismissed with prejudice.

Dated: May 9 , 2022

I certify that the foregoing is a true copy of the Order of Dismissal of the Armed

Services Board of Contract Appeals in ASBCA No. 63188

, Appeal of Booz Allen

Hamilton, Inc. , rendered in conformance with the Board’s Charter.

Dated: May 9, 2022 JOHN J. THRASHER

Administrative Judge

Chairman

Armed Services Board

of Contract Appeals

PAULLA K. GATES

- LEWIS

Recorder, Armed Services

Board of Contract Appeals
JPAY, INC., petitioner, v. Cynthia KOBEL, et al.

No. 18-811.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Advancing Translational Sciences, Special Emphasis Panel.                    

*Date:*                         June 14, 2022.                    

*Time:*                         1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Center for Advancing Translational Sciences, National Institutes of Health,  6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Rahat (Rani) Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892, (301) 594-7319,                         *khanr2@csr.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS)

Dated: May 2, 2022. 

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-09693 Filed 5-5-22; 8:45 am]

BILLING CODE 4140-01-P
Cynthia DIVEGLIA, petitioner, v. PENNSYLVANIA DEPARTMENT OF TRANSPORTATION, BUREAU OF DRIVER LICENSING.

No. 17-1666.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Commonwealth Court of Pennsylvania denied.
Rafael D. KENNEDY, petitioner, v. ILLINOIS.

No. 17-9216.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Appellate Court of Illinois, Fourth District denied.
Alexander Patrick McARDLE, petitioner, v. UNITED STATES.

No. 17-864.

Supreme Court of the United States

Jan. 22, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         260,000
<SECURITIES>                                         0
<RECEIVABLES>                                  153,400
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                      10,259,100
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              15,077,700
<CURRENT-LIABILITIES>                                0
<BONDS>                                      7,220,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                15,077,700
<SALES>                                              0
<TOTAL-REVENUES>                               772,100
<CGS>                                                0
<TOTAL-COSTS>                                  316,000
<OTHER-EXPENSES>                               192,100
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             172,700
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    91,300
<EPS-BASIC>                                       0.59
<EPS-DILUTED>                                     0.59



</TABLE>
Alton HASTYE, petitioner, v. Diana TOLSON.

No. 16-8959.

Supreme Court of the United States

Oct. 2, 2017.

Petition for writ of certiorari to the Court of Appeals of Maryland denied.
Richard HERBERT, petitioner, v. CVS PHARMACY, et al.

No. 17-8963.

Supreme Court of the United States

Feb. 25, 2019.

Petition for rehearing denied.
Tamim ABDUL-SAMAD, aka Tamin Abdul-Samad, aka Brandon Harris, petitioner, v. UNITED STATES.

No. 18-8266.

Supreme Court of the United States

April 15, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
```
 
 
WHEAT - MINNEAPOLIS GRAIN EXCHANGE                                   Code-001626
FUTURES ONLY POSITIONS AS OF 05/03/11                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 5,000 BUSHELS)                         OPEN INTEREST:       57,421
COMMITMENTS
  20,310    1,503    2,053   21,070   39,879   43,433   43,435   13,988   13,986

CHANGES FROM 04/26/11 (CHANGE IN OPEN INTEREST:     -3,186)
      64       51   -2,401     -494     -830   -2,831   -3,180     -355       -6

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    35.4      2.6      3.6     36.7     69.5     75.6     75.6     24.4     24.4

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       68)
      31        5        9       24       23       56       36
```

----

Updated May 6, 2011
LaQuisha R. WORTHY, et vir, petitioners, v. DEUTSCHE BANK NATIONAL TRUST COMPANY.

No. 17-6278.

Supreme Court of the United States

Dec. 11, 2017.

Petition for writ of certiorari to the Appellate Court of Connecticut denied.
<PAGE>

                                                                    Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Philadelphia Consolidated Holding
Corp. (the "Company") on Form 10-Q for the period ended September 30, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Craig P. Keller, chief financial officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Craig P. Keller
------------------------------
Craig P. Keller
Chief Financial Officer
November 8, 2004
Jean COULTER, petitioner, v. Cathy BISSOON, Judge, United States District Court for the Western District of Pennsylvania, et al.

No. 18-497.

Supreme Court of the United States

March 18, 2019.

Petition for rehearing denied.
Exhibit 1.1  SCHEDULE FOR FORM OF TRUST DECLARATION   TrusteeDateAmount of Regulation S SharesLaguana Partners Ltd.5/1/20052,000,000Karsten Behrens7/24/20063,000,000Karsten Behrens12/12/20061,000,000      TRUST DECLARATION    TO ALL WHOM THESE PRESENTS SHALL COME, Karsten Behrens, a lawyer carrying on business and residing in Vevey, Switzerland (hereinafter called the "Trustee") hereby declares:  WHEREAS the Trustee holds an aggregate of2,000,000(two million) common shares of Holmes Herbs Inc., USA (a US company trading in the United States, OTC-BB) in the name of the Trustee (herein referred to as "Shares").  AND WHEREAS the Trustee hereby acknowledges that the right, title and interest of the Trustee in the Shares are held in the name of the Trustee for the sole purpose of temporary convenience and are held IN TRUST for Holmes Herbs Inc., (the "Beneficiary").  THE TRUSTEE DOES HEREBY DECLARE that he holds and stands possessed or will hold and stand possessed of the Shares and all benefits derived therefrom, and all dividends and advantages accruing thereon and shall take the profits thereof and the proceeds of sale in the event that any of the Shares are or any interest therein is sold or disposed of UPON TRUST for the Beneficiary and its legal representatives.  THE TRUSTEE HEREBY AGREES that he will transfer, sell or otherwise deal with the Shares only in accordance with the written instructions of the Beneficiary.  THE TRUSTEE is granted a trustee fee of 5% of the selling value of the shares, due and payable only as the shares are sold in whole or in part. The trustee fee will not be paid on any portion of the shares remaining unsold and returned to the Beneficiary at their request.  IN WITNESS WHEREOF, the Trustee, LAGUANA PARTNERS Ltd. does hereby execute this Trust Declaration as of this 1st day of May, 2005 in the City of Vevey Switzerland.   Agreed to by: Acknowledged by:   /s/ Karsten Behrens /s/ John F. Metcalfe ______________________________ ______________________________ Karsten Behrens Holmes Herbs Inc.
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000854709
<NAME> DAYTON SUPERIOR CORPORATION
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               OCT-01-1999
<CASH>                                           3,584
<SECURITIES>                                         0
<RECEIVABLES>                                   64,837
<ALLOWANCES>                                   (5,768)
<INVENTORY>                                     36,386
<CURRENT-ASSETS>                               106,080
<PP&E>                                          70,200
<DEPRECIATION>                                (28,100)
<TOTAL-ASSETS>                                 278,484
<CURRENT-LIABILITIES>                           46,312
<BONDS>                                        128,779
<PREFERRED-MANDATORY>                           47,030
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      39,776
<TOTAL-LIABILITY-AND-EQUITY>                   278,484
<SALES>                                        250,561
<TOTAL-REVENUES>                               250,561
<CGS>                                          156,381
<TOTAL-COSTS>                                  156,381
<OTHER-EXPENSES>                                62,658
<LOSS-PROVISION>                                   237
<INTEREST-EXPENSE>                               8,945
<INCOME-PRETAX>                                 22,577
<INCOME-TAX>                                    10,160
<INCOME-CONTINUING>                             12,417
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    12,417
<EPS-BASIC>                                       2.09
<EPS-DILUTED>                                     2.01


</TABLE>
GLEN ST. ANDREW COM., et al., v. Marsha WETZEL.

No. 18-626 (R46-10 / OT 2018).

Supreme Court of the United States

Feb. 22, 2019.

The petition for writ of certiorari was dismissed on February 19, 2019, pursuant to Rule 46.1 of the Rules of this Court.
# Official Journal C 289/2023

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 289 |
| | |
| English edition | Information and Notices | Volume 6617 August 2023 |

ISSN 1977-091X

Official Journal

of the European Union

C 289

English edition

Information and Notices

Volume 6617 August 2023

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2023/C 289/01 | Common catalogue of varieties of vegetable species – supplement H 2023/3 (
  1
  ) | 1 |
| 2023/C 289/02 | Common catalogue of varieties of agricultural plant species – supplement A 2023/3 (
  1
  ) | 108 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2023/C 289/01

Common catalogue of varieties of vegetable species – supplement H 2023/3 (
  1
  )

1

1

2023/C 289/02

Common catalogue of varieties of agricultural plant species – supplement A 2023/3 (
  1
  )

1

108

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
<PAGE>   1

                                                                    EXHIBIT 11

            PHILADELPHIA CONSOLIDATED HOLDING CORP. AND SUBSIDIARIES
                        COMPUTATION OF EARNINGS PER SHARE
          (Dollars and Share Data in Thousands, except Per Share Data)
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                      As of and For the Three     As of and For the Nine
                                                    Months Ended September 30,   Months Ended September 30,
                                                    --------------------------   --------------------------
                                                       1998         1997(1)        1998         1997(1)
                                                      -------       -------       -------       -------
<S>                                                   <C>           <C>           <C>           <C>   
Weighted Average Common Shares Outstanding             12,248        12,224        12,270        12,178
Weighted Average Share Equivalents  Outstanding         2,713         2,816         2,680         2,717
                                                      -------       -------       -------       -------
Weighted Average Shares and Share
 Equivalents Outstanding                               14,961        15,040        14,950        14,895
                                                      =======       =======       =======       =======
Net Income                                            $ 6,076       $ 4,468       $15,435       $12,082
                                                      =======       =======       =======       =======
Basic Earnings per Share                              $  0.50       $  0.37       $  1.26       $  0.99
                                                      =======       =======       =======       =======
Diluted Earnings per Share                            $  0.41       $  0.30       $  1.03       $  0.81
                                                      =======       =======       =======       =======
</TABLE>

(1)      1997 share information restated to reflect a two-for-one split of the
         Company's common stock distributed in November 1997.


                                       17
Travis THOMAS, petitioner, v. UNITED STATES.

No. 18-7913.

Supreme Court of the United States

March 18, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
Christopher Lee PRICE, petitioner, v. Jefferson S. DUNN, Commissioner, Alabama Department of Corrections, et al.

No. 18-8766 (18A1044).

Supreme Court of the United States

April 12, 2019.

Application for stay of execution of sentence of death presented to Justice THOMAS and by him referred to the Court denied. Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.

Justice GINSBURG, Justice BREYER, Justice SOTOMAYOR, and Justice KAGAN would grant the application for stay of execution.